Susok, L.
Said, S.
Reinert, D.
Mansour, R.
Scheel, C. H.
Becker, J. C.
Gambichler, T. http://orcid.org/0000-0001-7862-3695
Funding for this research was provided by:
Universitätsklinikum der Ruhr-Universität Bochum
Article History
Received: 17 November 2021
Accepted: 1 December 2021
First Online: 10 January 2022
Declarations
:
: LS has received speakers and/or advisory board honoraria from BMS, Sun-Pharma, MSD, and Novartis. TG has received speakers and/or advisory board honoraria from BMS, Sanofi-Genzyme, MSD, Novartis Pharma, Roche, Abbvie, Almirall, Janssen, Lilly, Pfizer, Pierre Fabre, Merck-Serono, outside the submitted work. J.C. Becker is receiving speaker’s bureau honoraria from Amgen, Pfizer, Merck-Serono and Sanofi, is a paid consultant/advisory board member for eTheRNA, Merck-Serono, Pfizer, 4SC and Sanofi. His group receives research grants from Bristol-Myers Squibb, Merck Serono, and Alcedis. The other authors report no conflicts or competing interests.